Quinolone derivative or salt thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S300000, C546S152000, C546S156000

Reexamination Certificate

active

07879878

ABSTRACT:
A platelet aggregation inhibitor comprising a quinolone derivative or a pharmaceutically acceptable salt thereof as an active ingredient, and a novel quinolone derivative or a pharmaceutically acceptable salt thereof useful as a platelet aggregation inhibitor.

REFERENCES:
patent: 3943141 (1976-03-01), Ellis et al.
patent: 4024255 (1977-05-01), Ellis et al.
patent: 5024998 (1991-06-01), Bodor
patent: 5106837 (1992-04-01), Carson et al.
patent: 5324718 (1994-06-01), Loftsson
patent: 5506214 (1996-04-01), Beutler
patent: 5648368 (1997-07-01), Egbertson et al.
patent: 5753666 (1998-05-01), Beasley et al.
patent: 5889009 (1999-03-01), Miyake et al.
patent: 6121287 (2000-09-01), Bjork et al.
patent: 6130231 (2000-10-01), Wityak et al.
patent: 6136823 (2000-10-01), Sakae et al.
patent: 6248739 (2001-06-01), Turner et al.
patent: 6358976 (2002-03-01), Wityak et al.
patent: 6458788 (2002-10-01), Vaillancourt et al.
patent: 6875869 (2005-04-01), Jansson
patent: 7488739 (2009-02-01), Watanuki et al.
patent: 2002/0025961 (2002-02-01), Scarborough et al.
patent: 2002/0077486 (2002-06-01), Scarborough et al.
patent: 2002/0132806 (2002-09-01), Ruggeri et al.
patent: 2003/0060474 (2003-03-01), Bryant et al.
patent: 2003/0144305 (2003-07-01), Hardern et al.
patent: 2003/0153556 (2003-08-01), Levy et al.
patent: 2003/0162774 (2003-08-01), Scarborough et al.
patent: 2004/0147576 (2004-07-01), Scarborough et al.
patent: 2004/0186131 (2004-09-01), Wathen et al.
patent: 0945435 (1999-09-01), None
patent: 1433774 (1976-04-01), None
patent: 2372986 (2002-09-01), None
patent: 50-29574 (1975-03-01), None
patent: 50-35191 (1975-04-01), None
patent: 2001-139555 (2001-05-01), None
patent: 2002-531567 (2002-09-01), None
patent: 97/04779 (1997-02-01), None
patent: 98/23592 (1998-06-01), None
patent: 99/32450 (1999-07-01), None
patent: 00/34283 (2000-06-01), None
patent: 00/40561 (2000-07-01), None
patent: 00/40563 (2000-07-01), None
patent: 01/25239 (2001-04-01), None
patent: 01/57037 (2001-08-01), None
patent: 02/06513 (2002-01-01), None
patent: 02/070487 (2002-09-01), None
patent: 02/092571 (2002-11-01), None
patent: 02/098856 (2002-12-01), None
patent: 03/022214 (2003-03-01), None
patent: 2004/019932 (2004-03-01), None
International Search Report dated Oct. 26, 2004, in PCT/JP2004/010781.
Database Chemcats on STN, Accession No. 2003:2205826, Registry No. 375351-23-8 (2003), p. 1.
Database Chemcats on STN-Accession No. 2002:163154, Registry No. 375351-23-8 (2002), p. 1.
Nancee L. Oien et al., “Broad-Spectrum Antiherpes Activities of 4-Hydroxyquinoline Carboxamides, a Novel Class of Herpesvirus Polymerase Inhibitors”, Antimicrobial Agents and Chemotherapy, 2002, 46(3): 724-730.
C. Lossasso et al., “Effects of Lomefloxacin and Sparfloxacin on Human Platelet Aggregation”, Journal of Chemotherapy, 1995, 7(5):420-423.
European Office Action issued in Application No. 04 748 045.4—1216, dated Oct. 12, 2009.
Mexican Office Action dated Sep. 11, 2009.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Quinolone derivative or salt thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinolone derivative or salt thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolone derivative or salt thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2645682

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.